276 related articles for article (PubMed ID: 31495513)
21. mTOR pathway activation in focal cortical dysplasia.
Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions.
Dai L; Huang J; Shen KF; Yang XL; Zhu G; Zhang L; Wang ZK; Liu SY; Liao X; Xu SL; Yang H; Li XY; Zhang CQ
Histol Histopathol; 2024 Jan; ():18707. PubMed ID: 38293776
[TBL] [Abstract][Full Text] [Related]
23. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
Zimmer TS; Ciriminna G; Arena A; Anink JJ; Korotkov A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Baayen JC; Idema S; Rensing NR; Wong M; Mills JD; van Vliet EA; Aronica E
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431
[TBL] [Abstract][Full Text] [Related]
24. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
Nguyen LH; Mahadeo T; Bordey A
J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
[TBL] [Abstract][Full Text] [Related]
25. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H
J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
[TBL] [Abstract][Full Text] [Related]
26. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
[TBL] [Abstract][Full Text] [Related]
27. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.
Zurolo E; Iyer A; Maroso M; Carbonell C; Anink JJ; Ravizza T; Fluiter K; Spliet WG; van Rijen PC; Vezzani A; Aronica E
Brain; 2011 Apr; 134(Pt 4):1015-32. PubMed ID: 21414994
[TBL] [Abstract][Full Text] [Related]
28. Expression and cellular distribution of FGF13 in cortical tubers of the tuberous sclerosis complex.
Wu K; Yue J; Shen K; He J; Zhu G; Liu S; Yang H; Zhang CQ
Neurosci Lett; 2021 Apr; 749():135714. PubMed ID: 33582188
[TBL] [Abstract][Full Text] [Related]
29. Doublecortin expression in focal cortical dysplasia in epilepsy.
Srikandarajah N; Martinian L; Sisodiya SM; Squier W; Blumcke I; Aronica E; Thom M
Epilepsia; 2009 Dec; 50(12):2619-28. PubMed ID: 19583780
[TBL] [Abstract][Full Text] [Related]
30. Cell injury and premature neurodegeneration in focal malformations of cortical development.
Iyer A; Prabowo A; Anink J; Spliet WG; van Rijen PC; Aronica E
Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
[TBL] [Abstract][Full Text] [Related]
31. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
Veersema TJ; de Neef A; van Scheppingen J; Ferrier CH; van Eijsden P; Gosselaar PH; van Rijen PC; Spliet WGM; Braun KPJ; Mühlebner A; Aronica E
Int J Dev Neurosci; 2019 Dec; 79():96-104. PubMed ID: 31770571
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II.
Zhang Z; Liu Q; Liu M; Wang H; Dong Y; Ji T; Liu X; Jiang Y; Cai L; Wu Y
J Neuroinflammation; 2018 Jan; 15(1):27. PubMed ID: 29382328
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
[TBL] [Abstract][Full Text] [Related]
35. Identifying cellular signalling molecules in developmental disorders of the brain: Evidence from focal cortical dysplasia and tuberous sclerosis.
Li YF; Scerif F; Picker SR; Stone TJ; Pickles JC; Moulding DA; Avery A; Virasami A; Fairchild AR; Tisdall M; Harkness W; Cross JH; Hargrave D; Guillemot F; Paine SM; Yasin SA; Jacques TS
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):781-795. PubMed ID: 33797808
[TBL] [Abstract][Full Text] [Related]
36. Expression Patterns of TRPC1 in Cortical Lesions from Patients with Focal Cortical Dysplasia.
Zang Z; Li S; Zhang W; Chen X; Zheng D; Shu H; Guo W; Zhao B; Shen K; Wei Y; Zheng X; Liu S; Yang H
J Mol Neurosci; 2015 Oct; 57(2):265-72. PubMed ID: 26280213
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions.
Prabowo AS; Iyer AM; Anink JJ; Spliet WG; van Rijen PC; Aronica E
J Neuroinflammation; 2013 Jan; 10():12. PubMed ID: 23347564
[TBL] [Abstract][Full Text] [Related]
38. Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.
Schick V; Majores M; Koch A; Elger CE; Schramm J; Urbach H; Becker AJ
Epilepsia; 2007; 48 Suppl 5():65-73. PubMed ID: 17910583
[TBL] [Abstract][Full Text] [Related]
39. Hyaline protoplasmic astrocytopathy in the setting of tuberous sclerosis.
Prayson RA
J Clin Neurosci; 2016 Sep; 31():35-6. PubMed ID: 27174083
[TBL] [Abstract][Full Text] [Related]
40. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
